Table 5.
TLR3–/TSLP– | TLR3+/TSLP- | TLR3–/TSLP+ | TLR3+/TSLP+ | |
---|---|---|---|---|
Patients (n = 218) | 127 (58.25%) | 77 (35.33%) | 9 (4.13%) | 5 (2.29%) |
Controls (n = 360) | 145 (40.27%) | 132 (36.65%) | 46 (12.77%) | 37 (10.27%) |
OR (95% CI) | 1 | 0.66 (0.44–0.96) | 0.23 (0.10–0.53) | 0.16 (0.05–0.47) |
p | <0.0001 | 0.036 | 0.00014 | 0.00010 |
OR (95% CI) and p values were calculated using logistic regression.
EoE: eosinophilic esophagitis; TLR3: Toll-like receptor 3; TSLP: thymic stromal lymphopoietin; OR (95% CI): odds ratio with 95% confidence interval.